Sanofi, et al. v. Glenmark Pharmaceuticals Inc., et al., C.A. No. 14-264 - RGA, August 28, 2015.
Andrews, J. Claim Construction Opinion
The Court construed the following claim terms found in U.S. Patent Nos. 8,318,800; 7,323,493; and 8,410,167:
- solid pharmaceutical composition
- nonionic hydrophilic surfactant
- a method of decreasing a risk of cardiovascular hospitalization in a patent; a method of decreasing a risk of hospitalization for atrial fibrillation in a patient having a history of atrial fibrillation or atrial flutter
- effective amount
- to a patient in need thereof